A clinical study of MYM-V101

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 06 May 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

06 May 2019 New trial record
29 Apr 2019 According to the Mymetics Corporation media release, this trial will start on May 1, 2019 and is planned for five years. First results are expected to be reported in 2020.
29 Apr 2019 According to the Mymetics Corporation media release, this trial will be conducted in collaboration with world leading HIV scientists from the University of Louisiana at Lafayette and Texas Biomedical Research Institute. It is co-led by Drs. Ruprecht and Fleury and includes subawards to Dr. Francois Villinger of the University of Louisiana at Lafayette, and Dr. Sarah Ratcliffe of the University of Virginia.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com